Feasibility of Yoga for Type-2 Diabetes
This study will randomize 90 adults with type-2 diabetes (T2DM) from three different states (RI, MA, and AL) to a 12-week program of either (1) Iyengar yoga or (2) a Standard Exercise program. Follow up assessments occur at 3 and 6-months post-intervention. Results of this study will determine the ability to deliver these interventions with strong rigor and fidelity across multiple sites and will establish the feasibility and acceptability of this intervention across racially and ethnically diverse populations. The study will also examine factors (e.g., outcome expectations, barriers to home practice) that promote long-term adherence to yoga and/or physical activity.
Conditions:
🦠 Type2 Diabetes
🗓️ Study Start (Actual) 24 October 2022
🗓️ Primary Completion (Estimated) 31 December 2023
✅ Study Completion (Estimated) 31 May 2024
👥 Enrollment (Estimated) 90
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Providence, Rhode Island, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • 1. Age 18 years and older
    • 2. Diagnosis of type-2 diabetes, stable on medications
    • 3. Physician clearance

    Exclusion Criteria:

    • 1. Serious comorbid condition (such as uncontrolled hypertension, glaucoma, heart failure).
    • 2. Complications of diabetes such as diabetic retinopathy, neuropathy and nephropathy
    • 3. Serious psychiatric disorder (e.g. psychosis, major depression, panic attacks, suicidality, or substance dependence).
    • 4. Extremely obese (i.e. Body Mass Index \> 45 kg/m2)
    • 5. Currently engaged in yoga, Tai Chi, or other mindfulness-based practice the past six months
    • 6. Pregnant or trying to become pregnant
    • 7. Inability to read and write English
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 4 July 2021
  • First Submitted that Met QC Criteria 20 July 2021
  • First Posted 29 July 2021

Study Record Updates

  • Last Update Submitted that Met QC Criteria 18 April 2023
  • Last Update Posted 20 April 2023
  • Last Verified April 2023